AKEBIA THERAPEUTICS INC earnings per share and revenue

AX9 earnings per share for the last quarter are -0.08 EUR whereas the estimation was -0.07 EUR which accounts for -25.06% surprise. Company revenue for the same period amounts to 30.22 M EUR despite the estimated figure of 42.71 M EUR. Estimated earnings per share for the next quarter are -0.05 EUR, and revenue is expected to reach 45.66 M EUR. Also watch annual changes over time to get a bigger picture of AX9 earnings per share and revenue dynamics.